key articles
Co-morbidities in older prostate cancer patients play bigger role in mortality rates
Thursday, 23 May 2013- Older, sicker men with non-aggressive prostate cancer had a significantly greater risk of dying of causes other than prostate cancer, a risk that increased with age at diagnosis and comorbidities, data from...
Posted by: JV
Intensity-modulated radiation therapy and conformal radiotherapy: similar rates of disease control after prostatectomy
Wednesday, 22 May 2013- Men with prostate cancer gained no obvious benefits from treatment with the dominant form of adjuvant radiation therapy as compared with an older, less expensive technique, an analysis of a government...
Posted by: JV
Long-term androgen deprivation therapy for prostate cancer leads to higher osteoporosis risk
Friday, 17 May 2013- Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer. However, among other side-effects, it can cause significant bone thinning in men on long-term treatment.
A new...
Posted by: JV
Higher prostate cancer risks for US veterans exposed to Agent Orange
Thursday, 16 May 2013- U.S. veterans exposed to the powerful herbicide Agent Orange had a significantly increased risk of high-grade prostate cancer, researchers found.
In a cohort of men who served in Vietnam, Agent Orange...
Posted by: JV
Effect of a suspension suture in addition to a total anatomical reconstruction in RALP
Wednesday, 15 May 2013- Continence post robotic assisted laparoscopic radical prostatectomy (RALP) is approximately 90% and many reconstructive techniques have been described to improve early continence.
T. T. Shah anc...
Posted by: JV
AUA on PSA testing: only after careful discussion and for men aged 55 to 69 years
Tuesday, 7 May 2013- Prostate-specific antigen (PSA) testing for prostate cancer screening should proceed only after careful discussion of risks and harms with patients, and should target men ages 55 to 69, according to the...
Posted by: JV
Intermittent androgen deprivation appears to be safer on PCa patients
Thursday, 2 May 2013- Intermittent androgen deprivation appears to be just as hard on relapsing or advanced prostate cancer as continuous dosing but easier on patients, a meta-analysis showed.
None of the nine studies comparing...
Posted by: JV
Consideration of comorbidity in risk stratification prior to prostate biopsy
Tuesday, 30 April 2013- Previously, the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-CaP) questionnaire and/or the physician-reported Charlson Comorbidity Index (CCI) have provided assessments of...
Posted by: JV
Using genetic variants to personalize prostate cancer screenings
Monday, 29 April 2013- With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine....
Posted by: JV
